U.S. Markets open in 24 mins.

Aratana Therapeutics, Inc. (PETX)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
7.00+0.02 (+0.29%)
At close: 4:00PM EDT
People also watch
OMEROMEDOCULPTCTPTLA
Full screen
Previous Close6.98
Open6.98
Bid5.79 x 200
Ask7.50 x 100
Day's Range6.82 - 7.02
52 Week Range4.97 - 10.73
Volume1,055,802
Avg. Volume379,114
Market Cap294.49M
Beta3.17
PE Ratio (TTM)-8.91
EPS (TTM)-0.79
Earnings DateAug 2, 2017 - Aug 7, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Trade prices are not sourced from all markets
  • Capital Cube10 days ago

    ETFs with exposure to Aratana Therapeutics, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aratana Therapeutics, Inc. Here are 5 ETFs with the largest exposure to PETX-US. Comparing the performance and risk of Aratana Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Aratana Therapeutics, Inc. :PETX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
    Capital Cube12 days ago

    Aratana Therapeutics, Inc. :PETX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Aratana Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Aratana Therapeutics, Inc. – Zoetis, Inc. Class A, Eli Lilly and Company, Pacira Pharmaceuticals, Inc., Phibro Animal Health Corporation Class A, ImmuCell Corporation, Merck & Co., Inc., Heska ... Read more (Read more...)

  • PR Newswirelast month

    Aratana Therapeutics to Participate at Three Upcoming Investment Conferences

    LEAWOOD, Kan., May 16, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics ...